EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phytocannabinoids in the Pharmacotherapy of Psoriasis

Adam Wroński, Iwona Jarocka-Karpowicz iD, Anna Stasiewicz iD, Elżbieta Skrzydlewska iD

Molecules · 2023

DOI: 10.3390/molecules28031192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Adam Wroński und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatological Specialized Center "DERMAL" NZOZ in Bialystok, 15-453 Bialystok, Poland. Hauptthemen laut MEDLINE: Psoriasis, Skin Diseases, Cannabidiol. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phytocannabinoids are naturally occurring compounds, the main source of which is Cannabis sativa L. Through direct action or interaction with G protein-coupled receptors, they affect ROS and pro-inflammatory cytokines levels and modify the effectiveness of transcription factor responsible for the biosynthesis of antioxidants which lead to oxidative stress and its consequences. Due to the modification of the redox balance and inflammation, phytocannabinoids are used in the treatment of various diseases, including autoimmune dermatoses, such as atopic dermatitis and psoriasis. Psoriasis is one of the most common dermatoses, and one of unknown etiology. A disturbed redox balance with a shift towards the oxidation leads to oxidative stress, resulting in oxidative modifications, mainly of lipids and proteins, and prolonged activation of immune cells and increased generation of pro-inflammatory cytokines, resulting in chronic inflammation. Given the biological activity of phytocannabinoids, they have become the focus of research as components of pharmacotherapy for psoriasis. Beneficial effects were shown by various representatives of phytocannabinoids, but the effect of cannabidiol (CBD) on skin cells (in vitro and ex vivo) and on blood cells from patients with psoriasis vulgaris and psoriatic arthritis has been most often evaluated in recent years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisSkin DiseasesCannabidiolHumansSkinCytokinesInflammation

Stichwörter der Autor:innen

CBDblood cellsinflammationoxidative stressphytocannabinoidspsoriasisskin cells

Substanzen

CannabidiolCytokines

Autor:innen und Institutionen

  • Dermatological Specialized Center "DERMAL" NZOZ in Bialystok, 15-453 Bialystok, Poland.
  • Department of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.

ORCID-Profile: Iwona Jarocka-Karpowicz, Anna Stasiewicz, Elżbieta Skrzydlewska

Zitieren

APA

Wroński, A., Jarocka-Karpowicz, I., Stasiewicz, A., & Skrzydlewska, E. (2023). Phytocannabinoids in the Pharmacotherapy of Psoriasis. Molecules. https://doi.org/10.3390/molecules28031192

Vancouver

Wroński A, Jarocka-Karpowicz I, Stasiewicz A, Skrzydlewska E. Phytocannabinoids in the Pharmacotherapy of Psoriasis. Molecules. 2023. doi:10.3390/molecules28031192

BibTeX
@article{Wroski2023,
  author = {Wroński, Adam and Jarocka-Karpowicz, Iwona and Stasiewicz, Anna and Skrzydlewska, Elżbieta},
  title = {Phytocannabinoids in the Pharmacotherapy of Psoriasis},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28031192}
}
Kostenlos starten →